[190 Pages Report] The Oligonucleotide Synthesis Market size was estimated at USD 10.29 billion in 2023 and expected to reach USD 12.24 billion in 2024, at a CAGR 20.24% to reach USD 37.41 billion by 2030.
Oligonucleotide synthesis is a chemical process that involves the automated assembly of single-stranded DNA or RNA molecules, referred to as oligonucleotides. This process is used in various applications, including research and development, drug discovery, gene therapy, and forensic science. The rising prevalence of chronic diseases worldwide is resulting in increased drug discovery and research activities and is facilitating the use of the oligonucleotide synthesis process to develop efficient drugs and therapeutics. The increasing investments in pharmaceutical and biotechnology research are expanding the use of oligonucleotide synthesis processes to create custom nucleic acid sequences that can be used for targeted gene expression, diagnostic testing, and therapeutic agents. However, the high cost of production and issues in large-scale oligonucleotide synthesis may adversely impact the use of the oligonucleotide synthesis process by the end-use sectors. Moreover, the ongoing improvements and collaboration to expand the production of oligonucleotides are expected to encourage the use of the oligonucleotide synthesis processes by end-use industries worldwide.
Regional Insights
The oligonucleotide synthesis market is evolving in the Americas owing to the presence of a well-established healthcare sector, increasing drug and therapeutic research activities, and a growing need for improved diagnostic testing solutions. The rising prevalence of chronic diseases, government initiatives and investments in modernizing healthcare infrastructure, and increasing drug discovery and research is facilitating the use of the oligo synthesis process across the end-use sectors in the region. The growing need for early and efficient disease diagnosis, expanding life-science and medical research, and growing focus on developing improved diagnostic solutions are accelerating the use of the oligonucleotide synthesis processes by the research institutes and diagnostic laboratories in the EMEA region. Additionally, the ongoing research to minimize errors and enhance the quality and efficiency of the oligonucleotide synthesis process is anticipated to propel the growth of the oligonucleotide synthesis market worldwide.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Oligonucleotide Synthesis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Oligonucleotide Synthesis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Oligonucleotide Synthesis Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Ajinomoto Bio-Pharma Services, ATDBio Ltd., Bio-synthesis Inc., Biocomma Ltd., Biolegio B.V., Biolytic Lab Performance Inc., Bioserve India by Reprocell Group, Bon Opus Biosciences, LLC, Creative Biogene, Cusabio Technology LLC, Danaher Corporation, Eurofins Genomics LLC, Eurogentec S.A. by Kaneka Corporation, GE Healthcare Inc., Generi Biotech, Genscript Corporation, Hongene Biotech Corp., LGC Genomics Limited, Merck KGaA, Microsynth AG, Nitto Denko Avecia Inc., Novartis AG, Perkin Elmer, SLS Research Pvt Ltd., Synbio Technologies, TAG Copenhagen A/S, TCI Chemicals (India) Pvt. Ltd., Thermo Fisher Scientific Inc., and TriLink BioTechnologies, Inc..
Market Segmentation & Coverage
This research report categorizes the Oligonucleotide Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Product
- Equipment
- Linkers & Adaptor
- Probes
- Reagents & Consumables
- Services
- Synthesized Oligonucleotides
- Type
- Custom
- Pre-designed
- Application
- Diagnostic
- Research
- Therapeutic
- End-User
- Academic Research Institutes
- CROs & CMOs
- Diagnostic Laboratories & Hospitals
- Pharmaceutical & Biotechnology Companies
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Oligonucleotide Synthesis Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Oligonucleotide Synthesis Market?
- What are the technology trends and regulatory frameworks in the Oligonucleotide Synthesis Market?
- What is the market share of the leading vendors in the Oligonucleotide Synthesis Market?
- Which modes and strategic moves are suitable for entering the Oligonucleotide Synthesis Market?
US $
Euro €
GBP £
